Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes
Authors:
- Jae W. LeeJLJae W. Lee
- Robert F. GonzalezRGRobert F. Gonzalez
- Cheryl J. ChapinCCCheryl J. Chapin
- Justin BuschJBJustin Busch
- Jeffrey R. FinemanJFJeffrey R. Fineman
- Jorge A. GutierrezJGJorge A. Gutierrez
- 1 May 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 288 (5) , L950-L957
Abstract
Inhaled nitric oxide (NO) is a selective pulmonary vasodilator effective in treating persistent pulmonary hypertension in newborns and in infants following congenital heart disease surgery. Recently, multiple in vivo and in vitro studies have shown a negative effect of NO on surfactant activity as well as surfactant protein gene expression. Although the relationship between NO and surfactant has been studied previously, the data has been hard to interpret due to the model systems used. The objective of the current study was to characterize the effect of NO on surfactant protein gene expression in primary rat type II pneumocytes cultured on a substratum that promoted the maintenance of type II cell phenotype. Exposure to a NO donor, S-nitroso-N-acetylpenicillamine (SNAP), decreased surfactant protein (SP)-A, (SP)-B, and (SP)-C mRNA levels in type II pneumocytes in a time- and dose-dependent manner. The effect was mediated in part by an increase in endothelin-1 secretion and a decrease in the intracellular messenger, phosphorylated ERK1/2 mitogen-activated protein kinases (MAPK). Exposing type II pneumocytes to endothelin-1 receptor antagonists PD-156707 or bosentan before exposure to SNAP partially prevented the decrease in surfactant protein gene expression. The results showed that NO mediated the decrease in surfactant protein gene expression at least in part through an increase in endothelin-1 secretion and a decrease in phosphorylated ERK1/2 MAPKs.Keywords
This publication has 57 references indexed in Scilit:
- Increased pulmonary blood flow does not alter surfactant protein gene expression in lambs within the first week of lifeAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Bosentan: a dual endothelin receptor antagonistExpert Opinion on Investigational Drugs, 2002
- Isolation and Culture of Pulmonary Alveolar Epithelial Type II Cells2002
- Spatial Analysis of Key Signaling Proteins by High-content Solid-phase Cytometry in Hep3B Cells Treated with an Inhibitor of Cdc25 Dual-specificity PhosphatasesJournal of Biological Chemistry, 2001
- Superoxide Regulation of Endothelin-converting EnzymeJournal of Biological Chemistry, 2000
- Nitric oxide decreases surfactant protein A gene expression in H441 cellsCritical Care Medicine, 1998
- Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.Journal of Clinical Investigation, 1990
- Monoclonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988